Location History:
- Montreal, CA (1998)
- Quebec, CA (1988 - 2001)
- Cap-Rouge, CA (1989 - 2003)
Company Filing History:
2 out of 80 
1 out of 293 
2 out of 832,843 Years Active: 1988-2003
Title: Innovations and Contributions of Inventor Alain Belanger
Introduction
Alain Belanger is a notable inventor based in Cap-Rouge, Canada. He has made significant contributions to the field of medical treatment through his innovative patents. With a total of 5 patents, Belanger's work focuses on the development of inhibitors that play a crucial role in treating diseases sensitive to androgenic or estrogenic activity.
Latest Patents
Belanger's latest patents include groundbreaking methods for medical treatment. One of his notable inventions is the development of inhibitors of type 5 and type 3 17β-hydroxysteroid dehydrogenase. These inhibitors are designed to provide novel methods for treating diseases that are influenced by hormonal activity. Additionally, he has characterized an isolated uridine diphospho-glucuronosyltransferase (UGTB217), detailing methods for producing the enzyme and utilizing it to identify potential compounds that can alter its activity.
Career Highlights
Throughout his career, Alain Belanger has worked with various companies, including Endorecherche, Inc. His innovative approach and dedication to research have led to significant advancements in medical treatments. His patents reflect a deep understanding of biochemistry and its applications in healthcare.
Collaborations
Belanger has collaborated with esteemed colleagues such as Fernand Labrie and Andre Dupont. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the medical field.
Conclusion
Alain Belanger's contributions to the field of medical innovation are noteworthy. His patents and collaborative efforts demonstrate a commitment to advancing healthcare through scientific research and innovation.